J. Clin. Invest. 1983, 71, 1431-1441
200 UTERMANN G., HOPPICHLER F., DIEPLINGER H., SEED M.,
THOMPSON G.et al. Defects in the low density lipoprotein receptor gene affect
lipoprotein(a) levels: multiplicative interaction of two gene loci associated
with premature atherosclerosis.
Proc. Natl. Acad. Sci. USA 1989, 86,
4171-4174
201 PEROMBELON Y., GALLAGHER J., MYANT N., SOUTAR A.,
KNIGHT B. Lipoprotein(a) in subjects with familial defective zpolipoprotein
B100.
Atherosclerosis 1992, 92, 203-212
202 HOFMANN S., EATON D., BROWN M., McCONATHY W.,
GOLDSTEIN J., HAMMER R. Overexpression of human low density lipoprotein
receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic
mice.
J. Clin Invest. 1990, 85, 1542-1547
203 ARMSTRONG V., HARRACH B., ROBENEK H., HELMHOLD M.,
WALL! A., SEIDEL D. Heterogeneity of human lipoprotein Lp(a): cytochemical and
biochemical studies on the interaction of two Lp(a) species with the LDL
receptor.
J. Lipid Res. 1990, 31, 429-441
204 STEYER E., KOSTNER G.M.
Interaction of lipoprotein Lp(a) with the B/E-receptor: a
study using isolated bovine adrenal cortex and human fibroblast
receptors.
J. Lipid Res. 1990, 31, 1247-1253
205 THIERY J., ARMSTRONG V., SCHLEEF J., CREUTZFELDT C.,
CREUTZFELDT W., SEIDEL D. Serum lipoprotein Lp(a) concentrations are not
influenced by an HMG CoA Reductase Inhibitor. Klin. Wochenschr. 1988, 66,
462-463
los VESSBY B., KOSTNER G., LITHELL H., THOMIS
J.
Diverging effects of cholestyramine on apolipoproteinB
and lipoprotein(a). Atherosclerosis 1982, 44, 61-71
207 MAARTMANN -MOE K., BERG
K.
Lp(a) lipoprotein enters cultured fibroblasts
independently of the plasma membran low density lipoprotein
receptor.
Clin. Genet. 1981, 20, 352-362
208 SOUTAR A., Mc CARTHY S.,
SEED M., KNIGHT B.
Relationship between apolipoprotein(a) phenotype,
lipoprotein(a) concentration in plasma, and low density lipoprotein receptor
function in a large kindred with familial hypercholesterolemia due to the pro
664 -* leu mutation in the LDL receptor gene.
J. Clin. Invest. 1991, 88, 483-492
209 HARKES L., JURGENS G., HOLASEK A., VAN BERKEL
T.J.
In vivo studies on the binding sites for lipoprotein(a)
on parenchymal and non-parenchymal rat liver cells.
FEBS Letters 1988, 227, 27-31
210 HUNNINGHAKE D., STEIN E., MELLIES M.
Effects of one year of treatment with pravastatin, an
HMG-CoA Reductase Inhibitor, on lipoprotein(a). J. Clin. Pharmacol. 1993, 33,
574-580
211 KREMPLER F., KOSTNER G., ROSCHER A., HASLAUER F.,
BOLZANO K., SANDHOLZER F. Studies on the role of specific cell surface
receptors in the removal of lipoprotein(a) in man.
J. Clin. Invest. 1983, 71, 1431-1441
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 256/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
212 ROTHENEDER M., KREMPLER F., KOSTNER G.
Interaction of various lipoproteins from normal and
dyslipoproteinemic plasma with mouse peritoneal macrophages.
Ann. Biol. Clin. 1988, 46, 30-34
213 ZIONCHECK T., POWELL L., RICE G., EATON D., LAWN
R.
Interaction of recombinant apolipoprotein(a) and
lipoprotein(a) with macrophages. J. Clin. Invest. 1991, 87, 767-771
214 SNYDER M., POLACEK D., SCANU A., FLESS G.
Comparative binding and degradation of lipoprotein(a) and
low density lipoprotein by human monocyte-derived macrophages.
| 
